$ Value
$0
Shares
312
Price
$0
Filed
Aug 4
Insider
Name
Fishman Peter L.
Title
SVP, CFO
CIK
0002042862
Roles
Transaction Details
Transaction Date
2025-08-01
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
313
Footnotes
Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. | On August 8, 2022, the Reporting Person was granted 1,250 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in four equal installments on each of August 1, 2023, August 1, 2024, August 1, 2025, and August 1, 2026. | Not applicable. | Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. | Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion.
Filing Info
Fishman Peter L.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | AMRN | M | — |
| 2026-04-01 | AMRN | F | $897 |
| 2026-04-01 | AMRN | M | $0 |
| 2026-02-01 | AMRN | A | $0 |
| 2026-02-01 | AMRN | A | $0 |
| 2026-01-31 | AMRN | M | — |
| 2026-01-31 | AMRN | F | $5K |
| 2026-01-31 | AMRN | M | — |
| 2026-01-31 | AMRN | F | $16K |
| 2026-01-31 | AMRN | M | $0 |
Other Insiders at AMRN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Ketchum Steven B
EVP, Chief Scientific Officer
|
— | — | 2026-02-01 |
| Odysseas Kostas D | — | — | 2026-04-18 |
| Horn Keith | — | — | 2026-04-18 |
|
Berg Aaron
President and CEO
|
— | — | 2026-02-01 |
| Bonfiglio Patrice Eadon | — | — | 2026-04-18 |
| Sterling Louis III | — | — | 2026-04-18 |
| Sullivan Diane E. | — | — | 2026-04-18 |
| Cohen Paul | — | — | 2026-04-18 |
| O'Connor Oliver | — | — | 2026-04-18 |
|
Provoost Jonathan
EVP, Chief Legal Officer
|
— | — | 2026-02-01 |
|
Fishman Peter L.
SVP, CFO
|
— | — | 2026-04-01 |
|
Keenan David Paul
EVP, Chief Operating Officer
|
— | — | 2026-02-01 |